Category :

Medical Research Press Releases

New Molecular Test to Impact Influenza Pandemic Preparedness

New Molecular Test to Impact Influenza Pandemic Preparedness

InDevR Inc., a Boulder-based analytical technology and life science company, today announced plans to launch a Research Use Only (RUO) version of their FluChip-8G technology to aid in pandemic preparedness. The new molecular test addresses an unmet need for more detailed…

The CHEF1® Expression Technology Advantage for Accelerated Biologics Production, New Webinar Hosted by Xtalks

The CHEF1® Expression Technology Advantage for Accelerated Biologics Production, New Webinar Hosted by Xtalks

Biologics’ proprietary CHEF1® Expression System accelerates development of cell lines for cGMP biologics production. The innovative platform utilizes robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and CHEF1 expression plasmids, to produce high…

Vaccine Development Strategies for Stubborn Diseases: Battling the Measles and Mumps Comeback, New Webinar Hosted by Xtalks

Vaccine Development Strategies for Stubborn Diseases: Battling the Measles and Mumps Comeback, New Webinar Hosted by Xtalks

This upcoming presentation will address the challenges vaccine developers need to overcome when designing programs for resurgent diseases such as measles and mumps. The live session takes place on Thursday, Feb. 15, 2018 at 10 a.m. EST (3 p.m. GMT)…

Let's Go Robotics Announces Precise Drop™ Micro-Dispensing Systems

Let's Go Robotics Announces Precise Drop™ Micro-Dispensing Systems

​Let’s Go Robotics today announced Precise Drop™ micro-dispensing systems. These systems are the latest innovation by the company for life sciences and medical diagnostics applications. Precise Drop is highly configurable, making it easy to use in any environment from benchtop…

US Surgeon General to Speak at APS Conference on Analgesic Trials

Lotus Clinical Research is pleased to announce that United States Surgeon General, VADM Jerome M. Adams, MD, MPH, will address the American Pain Society’s Third Annual Conference on Analgesic Trials (APS-CAT) and APS’ Scientific Summit on Sunday, March 4, 2018 at the…

Foundation for Prader-Willi Research Announces Hire of Chief Executive Officer

​The Foundation for Prader-Willi Research (FPWR), a nonprofit organization dedicated to supporting research that advances the understanding and treatment of Prader-Willi syndrome (PWS), announced today that it has hired John Walter as its new Chief Executive Officer. Walter is the…

Enago Launches Open Access Journal Finder (OAJF) – Improving Accessibility of Authentic Open Access Journals

Enago Launches Open Access Journal Finder (OAJF) – Improving Accessibility of Authentic Open Access Journals

Enago, the leader in editing and publication support services, today announced the worldwide release of Open Access Journal Finder (OAJF) that aims at enabling research scholars to find open access journals relevant to their manuscript. OAJF uses a validated journal index provided by Directory…

Analysis: Nearly Two-Thirds of Online Reviewers Give Top-Ranked Hospitals Mediocre to Poor Marks

Of nearly 2,700 online reviews of the nation’s top-20 hospitals as ranked by U.S. News & World Report (USN&WR), almost two out of three reviewers give the facilities a mediocre to poor rating on the social media website Yelp.com, according to an analysis…

The Role of Clinical Data, Content, and Workflow in Selecting Study Sites

The Role of Clinical Data, Content, and Workflow in Selecting Study Sites

On Wednesday, January 24, 2018 at 1 p.m. EST Xtalks will host a complimentary webinar with Veeva Systems and Paragon Solutions. Topics will include how to use content, data, and workflow together to significantly optimize the site selection and activation processes.…

Strategy for Launch Success: Strategic Considerations for a Commercially Successful Biopharmaceutical Launch in Europe, New Webinar Hosted by Xtalks

Strategy for Launch Success: Strategic Considerations for a Commercially Successful Biopharmaceutical Launch in Europe, New Webinar Hosted by Xtalks

​​Achieving product approval and reimbursement in Europe for a new biopharmaceutical product is essential to ensuring that the product is successful. However, approval and reimbursement by themselves are not sufficient to ensure a commercially successful European launch. There are several…

Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer

​​​Sci-Engi-Medco Solutions Inc. (SEMCO), a private cancer drug discovery and development company that explores its proprietary small molecule anticancer agent technology, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 contract from the National…

CRO Industry Veteran Mike Wilkinson Joins Patient iP as President and COO

​Patient iP, a health data and analytics company providing patient data insights to accelerate and transform clinical research, today announced that Mike Wilkinson has been named company President and Chief Operating Officer effective immediately.  He will report directly to Chairman,…

Advanced BioMedical Technologies Inc. Commences Facility Upgrade

Advanced BioMedical Technologies Inc. Commences Facility Upgrade

​​Advanced Biomedical Technologies Inc. (OTCQB:ABMT), a developer and manufacturer of orthopaedic internal fixation devices, has announced the commencement of upgrading its facility in Shenzhen, China. The Company is renovating its Shenzhen GMP facility to meet new China Food and Drug Administration (“CFDA”) regulations and in…

Quantum Innovation's CEO, Noel Guillama, to Be Industry Speaker at Upcoming IoT Evolution Expo

Quantum Innovation's CEO, Noel Guillama, to Be Industry Speaker at Upcoming IoT Evolution Expo

​​​​The 19th IOT  Evolution Expo, being held January 22-25 , 2018 in Orlando Florida, will be the stage for Quantum Innovation’s CEO, Noel Guillama, as he speaks on the dynamic IoT (Internet of Things) and its fundamental  relationship to the future…

BASi Announces Enhanced Bioequivalence Capabilities

BASi Announces Enhanced Bioequivalence Capabilities

Bioanalytical Systems Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced a multi-tiered strategy aimed at enhancing the company’s in vitro and in vivo bioequivalence capabilities. Over the next several months, BASi will hire additional Principal Investigators and Research Analysts to support…

Polaryx Therapeutics Receives Orphan Drug Designation From the US FDA for the Treatment of Neuronal Ceroid Lipofuscinoses With PLX-100

Polaryx Therapeutics Receives Orphan Drug Designation From the US FDA for the Treatment of Neuronal Ceroid Lipofuscinoses With PLX-100

​Polaryx Therapeutics, Inc. is a biotech company developing patient-friendly oral small molecule therapeutics for Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) and other forms of NCL, commonly known as Batten disease. Neuronal Ceroid Lipofuscinoses qualify as rare pediatric diseases under Section 529…

A New Scientific Sleep App Recently Featured on Dr. Dan Gartenberg's TED.com Talk

A New Scientific Sleep App Recently Featured on Dr. Dan Gartenberg's TED.com Talk

Proactive Life LLC notes that Americans are sleeping on average one hour less than they did in the 1940s and more than 40 million Americans suffer from periodic or chronic insomnia. Sleep doctor and app developer Dr. Daniel Gartenberg created a…

Gladstone Institutes Announces Research Collaboration With Lilly

Gladstone Institutes Announces Research Collaboration With Lilly

The Gladstone Institutes announced today a new research collaboration with Eli Lilly and Company focused on neurodegenerative diseases. This multi-year, milestone-driven project will be based on a combination of innovative technologies developed at Gladstone by Steve Finkbeiner, M.D., Ph.D. His laboratory…

CMSC Receives Interprofessional Continuing Education Joint Accreditation for the Healthcare Team

CMSC Receives Interprofessional Continuing Education  Joint Accreditation for the Healthcare Team

​The Consortium of Multiple Sclerosis Centers (CMSC) is pleased to announce that it has received the maximum six-year accreditation as a provider of Interprofessional Continuing Education (IPCE).  As a jointly accredited provider, CMSC can now offer education and CE credits…

A Personalized Diagnostic Assay for the Treatment of Knee Injuries

An article published in Experimental Biology and Medicine (Volume 242, Issue 18, December 2017) describes a new approach for profiling patients with joint injuries. The study, led by Dr. Ursula Anderer, Professor for Cell Biology and Head of the Department Cell…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login